The industry might be asking why would the Department conduct the review after its interpretation of the criteria has already changed? Individual companies might be asking why the new interpretation has not applied to their requests? …
Latest Video
New Stories
-
Lung the leading cause of cancer mortality in 2019
March 22, 2019 - - Latest News -
Sigma: Sales of HCV therapies halve
March 22, 2019 - - Latest News -
Ex-Labor senator signs up with former health minister
March 22, 2019 - - Latest News -
MA 'building capacity and capability' on living therapies
March 22, 2019 - - Latest News -
Who will drive discussions about cell and gene therapies?
March 21, 2019 - - Latest News -
'Extending' the 'promise of immunotherapy'
March 21, 2019 - - Latest News -
Marcus Blackmore returns to lead company
March 21, 2019 - - Latest News